NRG Oncology Travel Support Request to #NRG19 in Philadelphia.Read more
RTOG 1119: Amendment 10 version date April 2, 2019 (posted to CTSU)
RTOG 0534: Amendment 8 version date January 15, 2019 (posted to CTSU)
RTOG 0534: Amendment 9 version date March 1, 2019 (posted to CTSU)
RTOG 0834 (The CATNON Intergroup Trial):
The QP (Medical Outcome Scale) and CS (Neurocognitive Assessment) forms have been revised to extend time points through year 12. The new forms, dated April 12, 2019, are posted to CTSU.
OTHER PROTOCOL NOTICES
NSABP B-55/BIG 6-13: Reminder! Accrual closure on April 29. Announcement (posted to CTSU)
NRG-GI002: Time Sensitive! Announcement of a revised projected date for temporary accrual suspension has been posted to the CTSU website.
NRG-GI006: A Participant Brochure is available on the CTSU website (CIRB Documents>Amendment Reviews>Support Documents #1).
Form TR for Biospecimens Shipped to NRG Biospecimen Bank-Columbus Read more
Biospecimen Bank-Columbus & SDMC Undergoing RefurbishmentRead more
4. Children’s Oncology Group Protocol AGCT1531: “A Phase III Trial of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors” is open to patient entry. It is available on the CTSU menu with Dr. Allan Covens as NRG Champion. Please enroll your eligible patients to this important trial. Enrollment credited to NRG Oncology will count towards membership requirements.
5. VTOC TRAINING
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, and NRG-CC004. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, May 8.
DRUG SAFETY UPDATES
Safety updates have been issued for the following studies:
WEBSITE FOR SAFETY REPORTS
NRG Oncology Travel Support Request to #NRG19 in Philadelphia
We support participation in our semiannual meetings through the provision of travel support. Priorities include young investigators, study chairs, engaged study champions, active committee members, member PIs and research staff actively engaged with NRG Oncology committees. Read more.
Please note the following upcoming meeting and abstract submission deadline dates
European Society for Medical Oncology (ESMO); Sep 27-Oct 1, 2019; Barcelona, Spain; due to publications committee Apr 30, 2019; meeting submission deadline May 8, 2019 9 pm CEST (Central European Summer Time); LBA Aug 21, 2019 9:00 pm CEST